An open-label, uncontrolled, long-term study to assess the safety of Lamictal in pediatric subjects previously enrolled in protocol LAM20006 and in Lamictal-naive subjects (1-24 months of age).

Trial Profile

An open-label, uncontrolled, long-term study to assess the safety of Lamictal in pediatric subjects previously enrolled in protocol LAM20006 and in Lamictal-naive subjects (1-24 months of age).

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Jan 2017

At a glance

  • Drugs Lamotrigine (Primary)
  • Indications Partial epilepsies
  • Focus Adverse reactions
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 20 May 2009 Primary outcome amended as reported by ClinicalTrials.gov.
    • 20 May 2009 Additional location identified as reported by ClinicalTrials.gov.
    • 04 Nov 2008 Checked against ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top